Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 932.55
+1.90 (0.20%)
Jun 13, 2025, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 19.49 billion as of June 13, 2025. Its market cap has increased by 50.43% in one year.
Market Cap
19.49B
Enterprise Value
17.42B
Revenue
7.60B
Ranking
n/a
PE Ratio
32.30
Stock Price
932.55
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 19.49B, an increase of 119.65%. That is a compound annual growth rate of 22.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 19.49B | -10.43% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,048.64B |
| Divi's Laboratories | 1,785.28B |
| Cipla | 1,213.80B |
| Apollo Hospitals Enterprise | 1,005.99B |
| Mankind Pharma | 986.42B |
| Zydus Lifesciences | 984.90B |
| Aurobindo Pharma | 670.94B |
| Alkem Laboratories | 579.47B |